1Inoue R, Tsuru T. ABO antigen blood group compatibility and al - lograft rejection in corneal transplantation [ J ]. Acta Ophthalmol Sec- ond ,1999.77:495 -498.
2Boisjoly HM, Bernard PM, Dube I ,et al. Effect of factors unrelated totissue matching on corneal transplant endothelial rejection. Am [ J ]. Ophthalmol. 1989,107:647 - 654.
3Volker - Dieben HJ, Class FH, Schreuder GM, et al. Beneficial effect of HLA - DR matching on the survival of corneal allografts [ J ]. Tramsplantatlon,2000,27:70(4) :640 -648.
4Plskova J, Holan V, Filipec M. et al. Lymph node removal enhances corneal graft survival in mice at high risk of rejection[J]. BMC Ophthalmol,2004,4:3 - 5.
5Nishi O, Nishi K, Fujiwara T, et al. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial. Br J Ophthalmol, 1996,80 ( 1 ) :63 - 68.
6Reinhard T,Henke L, et al. Penetrating limbo -keratoplasty for granu- lar and lattice corneal dystrophy - survival of donor limbal stem cells and intermediate - term clinical results [ J ]. Ophthalmologe, 2004 : 111:1528 -1533.
9Bumgardner GL,Li J,Prologo JD. et al. Patterns of immune responses evoked by allergenic hepatoeytes:evidence for independent co -dotalnant roles ofrCD4 andCD8 T - cell responses in acute rejection [ J ]. Transplantation, 1999,68 (4) : 555 ~ 562.
10Benedetti E, Kirby JP, Asolati M. et al. Transplantation [ J ], 1997,63 (9) :1206 - 1209.
二级参考文献15
1Hariharan S, Johnson CP, Bresnahan BA, et al. hnproved graft survival after renal transplantation in the United States. 1988 to 1996[M]. N Gngl J Meal,2000,342(9) : 605-12
2Pascual M,Theruvath T, Kawai T, et al. Strategies to improve long - term outcomes after renal transplantation [J ]. N Engl J Med,2002:346 (8) :580-590
3Clipstone NA, Crabtree GR. Identification of calcineurin as a key signaling enzyme in T - lymphocyte activation [ J ]. Nature, 1992,357 ( 6380 ) :696-697
5Olyaei AJ, de Mattos AM, Bennett WM. Nephrotoxicity of immunosuppresslve drugs:new ingight and preventive strategies [ J ]. Curr Opin Crit Care,2001,7 ( 6 ) :384-389
6Klein IH, Abrahams A, van Ede T,et al. Different effects of taerolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects [ J ]. Transplantation, 2002,73 ( 5 ) : 732-736
7Schnuelle P, Van der Heide JH, Tegzess, A, et al, Open randomized trial eomparing early withdrawal of either cyclosporine or myeophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen [ J ]. J Am Soe Nephrol,2002,13 ( 2 ) :536-543
8Smak Gregoor PJH, van Gelder T, Hesse C J, et al. Mycophenolic acid plasma concentrations in kidney allograft recipient with or with ont cyclosporine: a cross - sectional study. Nephrol Dial Transplant, 1999,14 ( 3 ) : 706-708
9Kahan BD,Rajagopalan PR,Michael H.Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody[].Transplantation.1999
10Hariharan S.Long term kidney transplant survival[].American Journal of Kidney Diseases.2001
